394800 fundamentals

3billion, Inc. engages in the provision of genetic testing and analyzing services to rare disease patients. The firm's products include 3B-Genome, 3B-Exome, 3B-Variant, and 3B-Interpreter. Its services include sequencing, artificial intelligence (AI) genetic mutation pathogenicity reading, full-length exome and genome analysis gene region, and proband target scope. The company was founded by Chang-Won Keum on October 10, 2016 and is headquartered in Seoul, South Korea.